State Street
ATXI

State Street’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

State Street’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-408
Closed -$4.51K – 4407
2024
Q1 		$4.51K Hold
408
– – ﹤0.01% 4353
2023
Q4 		$4.97K Hold
408
– – ﹤0.01% 4425
2023
Q3 		$21.5K Hold
408
– – ﹤0.01% 4433
2023
Q2 		$35.2K Hold
408
– – ﹤0.01% 4500
2023
Q1 		$35.8K Buy
+408
New +$37.7K ﹤0.01% 4585
2021
Q2 		– Sell
-128
Closed -$873K – 4492
2021
Q1 		$873K Buy
128
+35
+38% +$240K ﹤0.01% 3651
2020
Q4 		$622K Buy
93
+28
+43% +$147K ﹤0.01% 3625
2020
Q3 		$794K Buy
65
+5
+8% +$60.8K ﹤0.01% 3497
2020
Q2 		$721K Buy
+60
New +$677K ﹤0.01% 3488

Other funds holding ATXI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street's ATXI Position: Q2 2024 in Review

State Street sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q2 2024, closing a stake of 408 shares — an estimated $4.51K sold.

State Street first reported a position in ATXI in Q2 2020 and held it in 9 quarters. The position peaked at $873K in Q1 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

  • State Street reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Street sold 408 Avenue Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.51K.
  • State Street first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • State Street's Avenue Therapeutics, Inc. Common Stock position peaked at $873K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.